|
1
|
Curado MP and Boyle P: Epidemiology of
head and neck squamous cell carcinoma not related to tobacco or
alcohol. Curr Opin Oncol. 25:229–234. 2013.PubMed/NCBI
|
|
2
|
Sturgis EM and Cinciripini PM: Trends in
head and neck cancer incidence in relation to smoking prevalence:
An emerging epidemic of human papillomavirus-associated cancers?
Cancer. 110:1429–1435. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mork J: Forty years of monitoring head and
neck cancer in Norway - no good news. Anticancer Res. 18:3705–3708.
1998.PubMed/NCBI
|
|
4
|
Brunin F, Mosseri V, Jaulerry C, Point D,
Cosset JM and Rodriguez J: Cancer of the base of the tongue: Past
and future. Head Neck. 21:751–759. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Listl S, Jansen L, Stenzinger A, Freier K,
Emrich K, Holleczek B, Katalinic A, Gondos A and Brenner H: GEKID
Cancer Survival Working Group: Survival of patients with oral
cavity cancer in Germany. PLoS One. 8:e534152013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Eckert AW, Kappler M, Schubert J and
Taubert H: Correlation of expression of hypoxia-related proteins
with prognosis in oral squamous cell carcinoma patients. Oral
Maxillofac Surg. 16:189–196. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Michailidou E, Tzimagiorgis G,
Chatzopoulou F, Vahtsevanos K, Antoniadis K, Kouidou S, Markopoulos
A and Antoniades D: Salivary mRNA markers having the potential to
detect oral squamous cell carcinoma segregated from oral
leukoplakia with dysplasia. Cancer Epidemiol. 43:112–118. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gleber-Netto FO, Yakob M, Li F, Feng Z,
Dai J, Kao HK, Chang YL, Chang KP and Wong DT: Salivary biomarkers
for detection of oral squamous cell carcinoma in a Taiwanese
population. Clin Cancer Res. 22:3340–3347. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Fábryová H and Celec P: On the origin and
diagnostic use of salivary RNA. Oral Dis. 20:146–152. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wiklund ED, Gao S, Hulf T, Sibbritt T,
Nair S, Costea DE, Villadsen SB, Bakholdt V, Bramsen JB, Sørensen
JA, et al: MicroRNA alterations and associated aberrant DNA
methylation patterns across multiple sample types in oral squamous
cell carcinoma. PLoS One. 6:e278402011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brinkmann O and Wong DT: Salivary
transcriptome biomarkers in oral squamous cell cancer detection.
Adv Clin Chem. 55:21–34. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu CJ, Lin SC, Yang CC, Cheng HW and
Chang KW: Exploiting salivary miR-31 as a clinical biomarker of
oral squamous cell carcinoma. Head Neck. 34:219–224. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Matse JH, Yoshizawa J, Wang X, Elashoff D,
Bolscher JG, Veerman EC, Bloemena E and Wong DT: Discovery and
prevalidation of salivary extracellular microRNA biomarkers panel
for the noninvasive detection of benign and malignant parotid gland
tumors. Clin Cancer Res. 19:3032–3038. 2013.PubMed/NCBI
|
|
14
|
Friedman RC, Farh KK, Burge CB and Bartel
DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome
Res. 19:92–105. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guarnieri DJ and DiLeone RJ: MicroRNAs: A
new class of gene regulators. Ann Med. 40:197–208. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Stefani G and Slack FJ: Small non-coding
RNAs in animal development. Nat Rev Mol Cell Biol. 9:219–230. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hunter P: The great leap forward. Major
evolutionary jumps might be caused by changes in gene regulation
rather than the emergence of new genes. EMBO Rep. 9:608–611. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hanson EK, Lubenow H and Ballantyne J:
Identification of forensically relevant body fluids using a panel
of differentially expressed microRNAs. Anal Biochem. 387:303–314.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zubakov D, Boersma AW, Choi Y, van Kuijk
PF, Wiemer EA and Kayser M: MicroRNA markers for forensic body
fluid identification obtained from microarray screening and
quantitative RT-PCR confirmation. Int J Legal Med. 124:217–226.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Weber JA, Baxter DH, Zhang S, Huang DY,
Huang KH, Lee MJ, Galas DJ and Wang K: The microRNA spectrum in 12
body fluids. Clin Chem. 56:1733–1741. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Park NJ, Zhou H, Elashoff D, Henson BS,
Kastratovic DA, Abemayor E and Wong DT: Salivary microRNA:
Discovery, characterization, and clinical utility for oral cancer
detection. Clin Cancer Res. 15:5473–5477. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Boldrup L, Coates PJ, Wahlgren M, Laurell
G and Nylander K: Subsite-based alterations in miR-21, miR-125b,
and miR-203 in squamous cell carcinoma of the oral cavity and
correlation to important target proteins. J Carcinog. 11:182012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP
and Wei WI: Mature miR-184 as potential oncogenic microRNA of
squamous cell carcinoma of tongue. Clin Cancer Res. 14:2588–2592.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Mintz PJ, Saetrom P, Reebye V, Lundbaek
MB, Lao K, Rossi JJ, Gaensler KM, Kasahara N, Nicholls JP, Jensen
S, et al: MicroRNA-181a* targets Nanog in a subpopulation of CD34
(+) cells isolated from peripheral blood. Mol Ther Nucleic Acids.
1:e342012. View Article : Google Scholar :
|
|
25
|
Weidhaas JB, Babar I, Nallur SM, Trang P,
Roush S, Boehm M, Gillespie E and Slack FJ: MicroRNAs as potential
agents to alter resistance to cytotoxic anticancer therapy. Cancer
Res. 67:11111–11116. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Boyerinas B, Park S-M, Hau A, Murmann AE
and Peter ME: The role of let-7 in cell differentiation and cancer.
Endocr Relat Cancer. 17:F19–F36. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pignon JP, Bourhis J, Domenge C and
Designé L: Chemotherapy added to locoregional treatment for head
and neck squamous-cell carcinoma: Three meta-analyses of updated
individual data. MACH-NC Collaborative Group. Meta-Analysis of
Chemotherapy on Head and Neck Cancer. Lancet. 355:949–955. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shah JP and Gil Z: Current concepts in
management of oral cancer - surgery. Oral Oncol. 45:394–401. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Forastiere AA, Goepfert H, Maor M, Pajak
TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, et
al: Concurrent chemotherapy and radiotherapy for organ preservation
in advanced laryngeal cancer. N Engl J Med. 349:2091–2098. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cooper JS, Fu K, Marks J and Silverman S:
Late effects of radiation therapy in the head and neck region. Int
J Radiat Oncol Biol Phys. 31:1141–1164. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Möller P, Perrier M, Ozsahin M and Monnier
P: A prospective study of salivary gland function in patients
undergoing radiotherapy for squamous cell carcinoma of the
oropharynx. Oral Surg Oral Med Oral Pathol Oral Radiol Endod.
97:173–189. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hey J, Setz J, Gerlach R, Janich M,
Sehlleier S, Schaller HG, Gernhardt CR and Kuhnt T:
Parotid-gland-sparing 3D conformal radiotherapy in patients with
bilateral radiotherapy of the head and neck region - results in
clinical practice. Oral Oncol. 45:e11–e17. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hey J, Setz J, Gerlach R, Janich M,
Hildebrandt G, Vordermark D, Gernhardt CR and Kuhnt T: Parotid
gland-recovery after radiotherapy in the head and neck region - 36
months follow-up of a prospective clinical study. Radiat Oncol.
6:1252011. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lyman JT and Wolbarst AB: Optimization of
radiation therapy, IV: A dose-volume histogram reduction algorithm.
Int J Radiat Oncol Biol Phys. 17:433–436. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hu X, Macdonald DM, Huettner PC, Feng Z,
El Naqa IM, Schwarz JK, Mutch DG, Grigsby PW, Powell SN and Wang X:
A miR-200 microRNA cluster as prognostic marker in advanced ovarian
cancer. Gynecol Oncol. 114:457–464. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hu X, Schwarz JK, Lewis JS Jr, Huettner
PC, Rader JS, Deasy JO, Grigsby PW and Wang X: A microRNA
expression signature for cervical cancer prognosis. Cancer Res.
70:1441–1448. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Saydam O, Shen Y, Würdinger T, Senol O,
Boke E, James MF, Tannous BA, Stemmer-Rachamimov AO, Yi M, Stephens
RM, et al: Downregulated microRNA-200a in meningiomas promotes
tumor growth by reducing E-cadherin and activating the
Wnt/beta-catenin signaling pathway. Mol Cell Biol. 29:5923–5940.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Braun J, Hoang-Vu C, Dralle H and
Hüttelmaier S: Downregulation of microRNAs directs the EMT and
invasive potential of anaplastic thyroid carcinomas. Oncogene.
29:4237–4244. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Xia H, Ng SS, Jiang S, Cheung WK, Sze J,
Bian XW, Kung HF and Lin MC: miR-200a-mediated downregulation of
ZEB2 and CTNNB1 differentially inhibits nasopharyngeal carcinoma
cell growth, migration and invasion. Biochem Biophys Res Commun.
391:535–541. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li Y, Tan W, Neo TW, Aung MO, Wasser S,
Lim SG and Tan TM: Role of the miR-106b-25 microRNA cluster in
hepatocellular carcinoma. Cancer Sci. 100:1234–1242. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Du L, Schageman JJ, Subauste MC, Saber B,
Hammond SM, Prudkin L, Wistuba II, Ji L, Roth JA, Minna JD, et al:
miR-93, miR-98, and miR-197 regulate expression of tumor suppressor
gene FUS1. Mol Cancer Res. 7:1234–1243. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Fang L, Deng Z, Shatseva T, Yang J, Peng
C, Du WW, Yee AJ, Ang LC, He C, Shan SW, et al: MicroRNA miR-93
promotes tumor growth and angiogenesis by targeting integrin-β8.
Oncogene. 30:806–821. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Yu XF, Zou J, Bao ZJ and Dong J: miR-93
suppresses proliferation and colony formation of human colon cancer
stem cells. World J Gastroenterol. 17:4711–4717. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Montanini L, Lasagna L, Barili V, Jonstrup
SP, Murgia A, Pazzaglia L, Conti A, Novello C, Kjems J, Perris R,
et al: MicroRNA cloning and sequencing in osteosarcoma cell lines:
Differential role of miR-93. Cell Oncol (Dordr). 35:29–41. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Chen L, Jiang M, Yuan W and Tang H:
Prognostic value of miR-93 overexpression in resectable gastric
adenocarcinomas. Acta Gastroenterol Belg. 75:22–27. 2012.PubMed/NCBI
|
|
47
|
Xiao ZG, Deng ZS, Zhang YD, Zhang Y and
Huang ZC: Clinical significance of microRNA-93 downregulation in
human colon cancer. Eur J Gastroenterol Hepatol. 25:296–301. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Johnson SM, Grosshans H, Shingara J, Byrom
M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack
FJ: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Li X, Zhang Y, Zhang Y, Ding J, Wu K and
Fan D: Survival prediction of gastric cancer by a seven-microRNA
signature. Gut. 59:579–585. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yu F, Yao H, Zhu P, Zhang X, Pan Q, Gong
C, Huang Y, Hu X, Su F, Lieberman J, et al: let-7 regulates self
renewal and tumorigenicity of breast cancer cells. Cell.
131:1109–1123. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tu HF, Lin SC and Chang KW: MicroRNA
aberrances in head and neck cancer: Pathogenetic and clinical
significance. Curr Opin Otolaryngol Head Neck Surg. 21:104–111.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Patel RS, Jakymiw A, Yao B, Pauley BA,
Carcamo WC, Katz J, Cheng JQ and Chan EK: High resolution of
microRNA signatures in human whole saliva. Arch Oral Biol.
56:1506–1513. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zubakov D, Kokshoorn M, Kloosterman A and
Kayser M: New markers for old stains: Stable mRNA markers for blood
and saliva identification from up to 16-year-old stains. Int J
Legal Med. 123:71–74. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Salazar C, Nagadia R, Pandit P,
Cooper-White J, Banerjee N, Dimitrova N, Coman WB and Punyadeera C:
A novel saliva-based microRNA biomarker panel to detect head and
neck cancers. Cell Oncol (Dordr). 37:331–338. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Murdoch-Kinch CA, Russo N, Griffith S,
Braun T, Eisbruch A and D'Silva NJ: Recovery of salivary epidermal
growth factor in parotid saliva following parotid sparing radiation
therapy: A proof-of-principle study. Oral Surg Oral Med Oral Pathol
Oral Radiol Endod. 111:64–70. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Liu CJ, Kao SY, Tu HF, Tsai MM, Chang KW
and Lin SC: Increase of microRNA miR-31 level in plasma could be a
potential marker of oral cancer. Oral Dis. 16:360–364. 2010.
View Article : Google Scholar : PubMed/NCBI
|
